UVB Light Therapy at Home Results with UV Tactus

Psoriasis, eczema, and vitiligo are well-established indications for NB-UVB phototherapy and respond very well to this treatment. When UVB light is recommended for a patient, home therapy is a wise and practical choice— particularly for vitiligo, where treatment often needs to continue over many months.

UVB Phototherapy at home is safe and effective when done properly, with the right medical device and guidance.

UV Tactus: built-in safety and effectiveness through the app:

• Uses established NB-UVB light therapy treatment protocols applied in dermatology clinics

• Guides each session based on your skin reaction and adherence

• Automatically calculates dose and helps track and follow treatment:

Precise dose control through UV Tactus device:

• UV Tactus is a certified medical device (CE MDR Class IIa) delivering the same NB UVB type of light as in hospital or clinic.

• It includes an integrated medical-grade dosimeter and measures ultraviolet light dose in millijoules (mJ) — not just time

• Ensures each session delivers the exact prescribed energy (UVB light), improving safety and consistency

• Powerful LEDs distribute UVB light evenly across every millimetre of the treatment area without heating. The device’s treatment surface is divided into four individually controlled zones, which can be used separately or combined to cover up to 106 cm².

In summary: The UV Tactus device and app work together to create a controlled, responsive system that mirrors clinic-based UVB light therapy — allowing patients with psoriasis, eczema, and vitiligo to treat safely, confidently, and consistently at home, even during long-term UVB light therapy treatment.

Narrowband UVB (311 nm) phototherapy is a highly effective, well-established treatment and is commonly used as a first- or second-line option for chronic skin conditions such as psoriasis, eczema, and vitiligo. Supported by decades of clinical use and international medical guidelines, it is widely recommended and prescribed by dermatologists as a safe, reliable therapy.

UVB phototherapy uses precisely controlled doses of UV light to effectively calm inflammation, slow excessive skin cell growth, support repigmentation, and promote natural skin healing. With regular, consistent light therapy sessions, the majority of patients experience significant and long-lasting improvement, often reducing their reliance on creams or other treatments.

• Clinical evidence and dermatology guidelines support home-based NB-UVB phototherapy for patients. When done correctly, home treatment can achieve results comparable to clinic-based phototherapy, while offering greater convenience, better adherence, and the ability to start treatment as soon as a flare-up occurs.
• However, safe and effective UVB light therapy at home depends on using a trusted medical device. 

How UV Tactus addresses dermatologists’ key concerns about phototherapy at home:

• CE - marked professional medical device (Class IIa, MDR 2017/745) for safe and effective use at home. It is certified by TÜV Rheinland (Germany) and meets the latest and most rigorous medical device regulatory frameworks. Registered with the MHRA for UK.

• It is the only home NB UVB phototherapy device with LED light source and a professional integrated dosimeter, enabling the same dose accuracy and protocols used in clinical settings. The dose of UV light is measured in joules, not time, reducing the risk of under or over-exposure.

• The UV Tactus app helps patients follow their personal treatmentprotocol correctly and consistently.

• Free one-to-one onboarding ensures a confident start, with ongoing guidance available after purchase.

This combination of UV Tactus’ advanced features delivers clinic-level results with the highest level of safety at home.

Please visit Results section where you can read UV Tactus patients' reviews and see Before and After treatment stories.

Concerns about skin cancer are completely understandable when considering any treatment that uses ultraviolet light. Risk of skin cancer is known to be influenced by excessive or uncontrolled UV light exposure, particularly UVA light, which is more strongly associated with photo-ageing and cancer. For this reason, older treatments such as PUVA (psoralen plus UVA) are known to carry a higher long-term cancer risk.¹³

• By contrast, narrowband UVB (NB-UVB) light therapy has been used in dermatology for many decades, and large long-term studies have not shown a proven association between NB-UVB light therapy treatment and an increased risk of cancer when it is prescribed, dosed and monitored correctly.³ NB-UVB light delivers a very specific UVB wavelength (311 nm) and does not emit UVA, which significantly improves its safety profile compared with older phototherapy methods.¹³
• Most research indicates that NB-UVB light carries little to no additional risk beyond normal everyday exposure to natural sunlight, while offering the advantage of controlled, medically targeted dosing rather than unpredictable sun exposure.⁴

As a precaution, dermatology guidelines recommend long-term skin monitoring only for patients who receive very high cumulative numbers of light therapy treatments (typically more than 500 whole-body sessions), particularly in individuals with additional risk factors such as fair skin or significant past sun exposure.¹

• When NB-UVB light is used at home, correct dosing and control are especially important. Dermatologists consistently emphasise that phototherapy at home should follow the same treatment protocols and dose accuracy used in clinics.¹

This is where UV Tactus plays an important role. UV Tactus is a regulated medical device for home use that delivers medical-grade NB-UVB (311 nm) without UVA, incorporates a professional-grade dosimeter to ensure accurate dosing, and allows treatment to follow established clinical protocols. The UV Tactus mobile app guides patients step by step through their prescribed treatment plan, helping to prevent over- or under-exposure, and patients also receive a free one-to-one video onboarding session so treatment starts confidently and correctly from day one.

When NB-UVB light therapy is delivered using a properly regulated home device, with accurate dosing, UVA-free light and appropriate guidance, it is considered a safe and well-established treatment with no demonstrated increase in cancer risk.¹³⁴

References:

¹ British Association of Dermatologists & British Photodermatology Group.

Guidelines for narrowband ultraviolet B phototherapy (2022).

British Journal of Dermatology.

National Institute for Health and Care Excellence (NICE).

Psoriasis: assessment and management. UK clinical guidance.

³ Boswell L et al.

Phototherapy for psoriasis – outdated or underused?

British Journal of Dermatology 2018; 179:1148–1156.

DOI: 10.1111/bjd.17021

⁴ Kosmadaki M, Antoniou C.

In: Katsambas AD et al. (eds.) European Handbook of Dermatological Treatments.

Springer Nature Switzerland AG, 2023.

DOI: 10.1007/978-3-031-15130-9_127

While there are few absolute contraindications to phototherapy, such as a history of light sensitivity, genetic predisposition to skin cancer, relative contraindications include a personal history of skin cancer or a poor response to past phototherapy.

It’s essential to discuss potential risks with your doctor, particularly if you have lighter skin, are taking sun-sensitizing medications, or are using immunosuppressive drugs.

UVB light therapy is not recommended for individuals with severe systemic diseases or those with photodermatoses, which worsen with light exposure. Always consult your doctor before starting phototherapy to ensure it's safe and appropriate for your specific condition.

Thanks to its versatile immune-modulating and cell-regulating effects, phototherapy can be used as an effective primary or secondary treatment for a wide range of dermatological conditions and skin diseases. Doctors and patients use UV Tactus light therapy to treat skin conditions such as: Psoriasis, Eczema, Atopic dermatitis, Neurodermitis, Vitiligo, Mycosis fungoides, Lichen planus, Pityriasis lichenoides, Morphoea (Scleroderma), Chronic urticaria, Pruritus, Photodermatoses, etc. 

Results depend on your specific condition and skin disease, how your skin responds, and how consistently you attend UVB therapy sessions (usually 3 times per week).

First results often appear after a few weeks, but UVB light therapy works gradually — consistency is crucial to achieve the best results and shorten the time to improvement.

• Psoriasis: A typical course averages around 25 sessions. Whe treating psoriasis, many patients see clear improvement within weeks and a significant reduction in the need for steroid creams by the end of the course.

• Vitiligo: Progress is slower and requires a longer-term approach, often with treatment continuing for several months and sometimes up to a year. Doctors usually assess for signs of repigmentation within the first six monthsbefore deciding whether to continue.

• Remission: After completing a course, many patients enjoy treatment-free periods, during which the skin remains stable or clear.

Phototherapy, particularly Narrowband UVB (NB-UVB) light therapy, is considered very safe and has been used for decades with well-established safety profiles. Unlike older treatments like PUVA, the largest studies on NB-UVB treatment have not shown an increased risk of skin cancer. UVB light therapy does not typically lose its effectiveness over time, meaning you can have repeated light therapy courses over many years. As a precaution, medical guidelines recommend that if you reach 500 sessions in your lifetime, you should receive regular specialist skin cancer checks.

• The long-term safety profile of NB-UVB light therapy is well-established from decades of clinical use. This stands in contrast to some newer systemic drugs, where robust data on risks associated with continuous, long-term use is still being gathered. This extensive track og UVB therapy record allows for clear, evidence-based safety protocols.

With the UV Tactus, You can treat various parts of the body, including and not limited: 

• Arms and legs (both flat and curved areas)
• Torso (chest, back, and abdomen) and buttocks
• Hands and feet
• Scalp (with the comb attachment for better access through hair)
• Face, ears, neck (you can treat eyelids with eyes closed)
• Nails
• Hard-to-reach areas, such as behind the knees, elbows, and other curved or uneven surfaces

Only with UV Tactus you get Flexible Treatment Zones
The device’s treatment surface is divided into four individually controlled zones, which can be combined to cover up to 106 cm².
With a button press, you choose the zone combination that matches the shape of the affected area and direct the UVB light precisely.
Why it matters: You ensure that light is targeted exactly where needed, while surrounding skin is protected from unnecessary UV light exposure.

Special comb attachment for Scalp Treatment
Magnetic comb gently parts the hair, allowing the NB-UVB light to reach directly into the scalp. The transparent comb ensures UV light transmission, while the durable teeth are strong and long-lasting. The device’s protective frame shields your hands from UVB light exposure during use.
Why it matters: Simple and convenient with a lightweight, ergonomic, palm-sized device — the comb attachment treats the scalp psoriasis and eczema effectively without irritating sensitive skin.

Every UV Tactus set includes two medical-grade silicone frames, designed for both flat and curved body surfaces. They ensure the ideal distance from the skin so the exact dose reaches the treatment area, while protecting healthy skin from unnecessary UV exposure.
Why it matters: UVB light is concentrated on the treatment zone and distributed evenly, while unaffected skin remains protected — making therapy more precise and safer.

Yes. NB-UVB light therapy can be used on its own or alongside other treatments, including topical treatments, systemic medications, and biologics.

Phototherapy is often part of a comprehensive treatment plan. Skin conditions such as psoriasis, eczema and vitiligo usually require long-term management rather than a single solution. Combining treatments can improve overall control, enhance results and reduce the need for stronger medications. At the same time, both doctors and patients frequently turn to UVB light therapy to help reduce reliance on steroid creams and minimise long-term steroid exposure where possible.

Along with phototherapy treatment you may continue with prescribed topical treatments — but avoiding application immediately before a UVB light therapy session, as creams can reduce light penetration and affect effectiveness. However, it is essential to consult your doctor first. Some medications — particularly photosensitising drugs or certain immunosuppressants — can increase sensitivity to UVB light. Your doctor can advise how to safely combine UV Tactus light therapy with your current treatment and adjust the plan to maximise safety and results.

After UVB light therapy session,  you may feel the skin dry, so regular use of emollients is recommended to maintain hydration, support the skin barrier, and improve comfort throughout the treatment period.